INVESTOR ALERT: Investigation of ADMA Biologics, Inc. (ADMA) Announced by Holzer & Holzer, LLC

Core Viewpoint - Holzer & Holzer, LLC is investigating ADMA Biologics, Inc. for potential violations of federal securities laws following allegations of inflated revenue growth due to channel stuffing practices [1] Company Investigation - Culper Research published a report claiming that ADMA's reported revenue growth of +20% in 2025 was misleading, estimating that actual revenues declined by 3% when excluding channel stuffing [1] - The report has led to a decline in ADMA's stock price, indicating market reaction to the allegations [1] Legal Context - Shareholders who purchased ADMA stock and incurred losses are encouraged to contact Holzer & Holzer for legal representation regarding their rights [2] - Holzer & Holzer is recognized as a top-rated securities litigation law firm, focusing on shareholder and investor representation in cases of corporate misconduct [3]